Low Dose Antenatal Corticosteroids for Late Preterm Delivery

Recruiting now · Not applicable

Conditions studied: Respiratory Morbidity, Preterm Labor

In brief

This is a study proposal for a clinical trial to evaluate the effectiveness of a reduced dose of antenatal betamethasone (a steroid medication) in preventing respiratory problems in late preterm infants (born between 34 and 36 weeks of gestation). The study will be conducted in medical centers in Israel and will involve women who are at high risk for delivering a late preterm infant. The participants will be randomly assigned to receive either a full dose (12 mg) or a quarter dose (3 mg) of betamethasone, administered 24 hours apart. The main outcome measure of the study will be the incidence of respiratory problems or neonatal death within 72 hours of delivery in the two groups. The study is designed to determine if the reduced dose of betamethasone is non-inferior (i.e., not significantly worse) than the full dose in preventing respiratory problems in late preterm infants.

Key facts

Study ID
NCT05698966
Run by
Rambam Health Care Campus
People needed
1510
Starts
2022-01-01
Expected to finish
2028-01-01
Last updated by the study team
2024-04-10

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.